期刊文献+

悬浮培养联合化疗药物筛选乳腺癌干细胞 被引量:6

Isolation and purification of breast cancer stem cells by suspension culture combined with chemotherapeutic agents
暂未订购
导出
摘要 背景与目的:数量上的稀少和不断分化的能力阻碍了肿瘤干细胞的分离和纯化,现有的筛选方法只是富集了异质性的肿瘤干细胞群,无法取得更为原始的、接近源头的肿瘤干细胞。本文以肿瘤干细胞假说为理论依据,探讨悬浮培养联合化疗药物分离、培养、纯化及鉴定小鼠乳腺癌干细胞的可行性研究。方法:无血清悬浮培养小鼠乳腺癌TM40D细胞,流式细胞仪检测CD44+CD24-细胞含量。选取CD44+CD24-含量最多代数的细胞,加入不同血浆峰浓度(peak plasma concentrations,PPC)的联合化疗药物紫杉醇和表柔比星,作用24 h后继续无血清培养,Annexin-V FITC/PI流式细胞仪法检测细胞凋亡。将筛选得到的细胞以不同的数量接种到BALB/C小鼠皮下,观察致瘤能力。结果:无血清悬浮培养第10代的细胞中CD44+CD24-比例最高(77%)。接种0.35 PPC组100个细胞即可见肿瘤生成。结论:小鼠乳腺癌TM40D细胞中存在肿瘤干细胞,悬浮培养联合化疗药物筛选乳腺癌干细胞在方法上是可行的。 Background and purpose: The scarcity in quantity and continuous differentiation ability severely compromise the isolation and purification of cancer stem cells ( CSCs). The existing sorting methods can only enrich CSCs as a het-erogeneous population. However, more primitive CSCs closer to the source still have not been identified. Based on the CSC hypothesis, we hereby explored the possibility of isolation, culture, purification and identification of murine breast cancer stem cells in suspension culture combined with anticancer regimens. Methods: TM40D murine breast cancer cells were cul- tured in serum-free medium. The expression of CD44^+CD24^- was measured by flow cytometry. Cells from the passage of TM40D cells with the highest expression of CD44^+CD24^- were treated in combination with anticancer agents pacilitaxel and epirubicin at different peak plasma concentrations (PPC) for 24 hours, and then maintained under suspension culture. The rate of apoptosis was examined by flow cytometry with Annexin-V FITC/PI double staining method. Selected cells in different amounts were injected subcutaneously into BALB/C mice to observe tumor formation. Results: Cells of passage 10 in suspension culture had the highest percentage of CD44^+CD24^-( about 77 percent). As few as 100 cells in 0.35 PPC could generate tumors in BALB/C mice. Conclusions: TM40D cell line contains breast cancer stem cells. This study suggested that suspension culture combined with anticancer regimens is a feasible approach for screening tumor stem cells.
出处 《中国癌症杂志》 CAS CSCD 2008年第3期172-175,共4页 China Oncology
关键词 肿瘤干细胞 悬浮培养 化疗药物 乳腺癌 移植瘤 cancer stem cells suspension culture chemotherapeutic agents breast cancer xenograft
  • 相关文献

参考文献9

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells,cancer, and cancer stem cells [ J ]. Nature ,2001,414 ( 6859 ) : 105-111.
  • 2Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci USA ,2003,100 (7) :3983-3988.
  • 3Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J]. Cancer Res , 2005,65(13) : 5506-5511.
  • 4Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG^2+ and ABCG^2- cancer cells are similarly tumorigenic[J]. Cancer Res, 2005,65(14) :6207-6219.
  • 5Chen AY, Yu C, Bodley A, et al. A new mammalian DNA topoisomerase Ⅰ poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures[ J]. Cancer Res, 1993,53 (6) : 1332-1337.
  • 6Singh S, Dwarakanath BS, Mathew TL. DNA ligand Hoechst- 33342 enhances UV induced cytotoxicity in human glioma cell lines[J]. J Photochem Photobiol B, 2004, 77(1-3) :45-54.
  • 7Siemann DW, Keng PC. Cell cycle specific toxicity of the Hoechst 33342 stain in untreated or irradiated murine tumor cells [J]. Cancer Res, 1986,46(7) :3556-3559.
  • 8Zheng X, Shen G, Yang X, et al. Most C6 cells are cancer stem cells : evidence from clonal and population analyses [ J ]. Cancer Res, 2007,67 ( 8 ) :3691-3697.
  • 9Dontu G, Wicha MS. Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia[ J ]. J Mammary Gland Biol Neoplasia ,2005,10( 1 ) :75-86.

同被引文献57

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部